Literature DB >> 17921723

Cancer stem cells: implications for cancer treatment and prevention.

Madhuri Kakarala1, Max S Wicha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17921723     DOI： 10.1097/PPO.0b013e318156da4e

Source DB:  PubMed          Journal:  Cancer J        ISSN： 1528-9117            Impact factor:   3.360


× No keyword cloud information.
  21 in total

Review 1.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 2.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

3.  Notch1 inhibition alters the CD44hi/CD24lo population and reduces the formation of brain metastases from breast cancer.

Authors:  Patricia M McGowan; Carmen Simedrea; Emeline J Ribot; Paula J Foster; Diane Palmieri; Patricia S Steeg; Alison L Allan; Ann F Chambers
Journal:  Mol Cancer Res       Date:  2011-06-10       Impact factor: 5.852

4.  Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.

Authors:  Ylenia Lombardo; Aleksandra Filipović; Gemma Molyneux; Manikandan Periyasamy; Georgios Giamas; Yunhui Hu; Pritesh S Trivedi; Jayson Wang; Ernesto Yagüe; Loren Michel; R Charles Coombes
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

5.  In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.

Authors:  Veronique Neumeister; Seema Agarwal; Jennifer Bordeaux; Robert L Camp; David L Rimm
Journal:  Am J Pathol       Date:  2010-03-12       Impact factor: 4.307

6.  Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.

Authors:  Anna Maria Calcagno; Crystal D Salcido; Jean-Pierre Gillet; Chung-Pu Wu; Jennifer M Fostel; Melanie D Mumau; Michael M Gottesman; Lyuba Varticovski; Suresh V Ambudkar
Journal:  J Natl Cancer Inst       Date:  2010-10-08       Impact factor: 13.506

7.  Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

Authors:  Amy M McCord; Muhammad Jamal; Uma T Shankavaram; Uma T Shankavarum; Frederick F Lang; Kevin Camphausen; Philip J Tofilon
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

Review 8.  Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?

Authors:  Antoinette R Tan; Gabriela Alexe; Michael Reiss
Journal:  Breast Cancer Res Treat       Date:  2008-10-09       Impact factor: 4.872

9.  USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A.

Authors:  Xiao-yong Zhang; Harla K Pfeiffer; Alan W Thorne; Steven B McMahon
Journal:  Cell Cycle       Date:  2008-03-18       Impact factor: 4.534

10.  Persistence of side population cells with high drug efflux capacity in pancreatic cancer.

Authors:  Jing Zhou; Chun-You Wang; Tao Liu; Bin Wu; Feng Zhou; Jiong-Xin Xiong; He-Shui Wu; Jing Tao; Gang Zhao; Ming Yang; Shan-Miao Gou
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.